This story has been updated to include pro forma financial information of the combined Quidel and Triage businesses.

NEW YORK (360Dx) – In an amended 8K filed with the US Securities and Exchange Commission late yesterday, Quidel provided detail on its acquisition of the Alere Triage and BNP businesses from Abbott, and provided updates on its legacy business and recent influenza testing tracking.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oct
02

In the last few years several molecular testing methodologies — such as immunohistochemistry, PCR, and sequencing — have been approved by the US Food and Drug Administration to aid in the management of patients with lung cancer.  

Oct
10

This webinar will provide a first-hand look at how the Dana-Farber Cancer Center is adapting its oncology care strategy in light of the rapidly evolving molecular landscape.

Nov
05
Sponsored by
Sophia Genetics

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.